- Home
- VSA vs MBRX Comparison
VSA vs MBRX Comparison
Compare VSA & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- MBRX
- Stock Information
- Founded
- VSA 2002
- MBRX 2015
- Country
- VSA China
- MBRX United States
- Employees
- VSA N/A
- MBRX 17
- Industry
- VSA
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- VSA
- MBRX Health Care
- Exchange
- VSA NYSE
- MBRX Nasdaq
- Market Cap
- VSA 12.6M
- MBRX 17.1M
- IPO Year
- VSA N/A
- MBRX 2016
- Fundamental
- Price
- VSA $1.27
- MBRX $0.71
- Analyst Decision
- VSA
- MBRX Strong Buy
- Analyst Count
- VSA 0
- MBRX 3
- Target Price
- VSA N/A
- MBRX $5.33
- AVG Volume (30 Days)
- VSA 209.8K
- MBRX 9.6M
- Earning Date
- VSA 08-21-2025
- MBRX 08-13-2025
- Dividend Yield
- VSA N/A
- MBRX N/A
- EPS Growth
- VSA N/A
- MBRX N/A
- EPS
- VSA N/A
- MBRX N/A
- Revenue
- VSA $160,411,283.00
- MBRX N/A
- Revenue This Year
- VSA N/A
- MBRX N/A
- Revenue Next Year
- VSA N/A
- MBRX N/A
- P/E Ratio
- VSA N/A
- MBRX N/A
- Revenue Growth
- VSA N/A
- MBRX N/A
- 52 Week Low
- VSA $0.18
- MBRX $0.25
- 52 Week High
- VSA $2.09
- MBRX $3.67
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- MBRX 56.31
- Support Level
- VSA N/A
- MBRX $0.53
- Resistance Level
- VSA N/A
- MBRX $0.96
- Average True Range (ATR)
- VSA 0.00
- MBRX 0.12
- MACD
- VSA 0.00
- MBRX 0.01
- Stochastic Oscillator
- VSA 0.00
- MBRX 47.07
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has two operating segments: the IT Professional Education segment and the IT-focused Supplementary STEM Education Services segment. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.